LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance ...
A new study suggests that methylene blue—a medication already approved for several clinical uses—may protect the lungs from damage caused by major heart surgeries that involve stopping blood ...
A new study, published today in The Lancet Respiratory Medicine, tested whether a set of interventions to keep lungs expanded before, during, and after abdominal surgery could lower the risk of ...
DULUTH — Aspirus St. Luke’s recently launched a fully operational extracorporeal membrane oxygenation program designed to rapidly initiate life-saving heart and lung support for critically ill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results